FY2019 EPS Estimates for Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share Boosted by SunTrust Banks (AVDL)

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) – Equities research analysts at SunTrust Banks lifted their FY2019 earnings per share estimates for shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share in a report released on Tuesday. SunTrust Banks analyst J. Boris now anticipates that the company will earn $0.15 per share for the year, up from their prior forecast of $0.11. SunTrust Banks also issued estimates for Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share’s FY2021 earnings at $2.16 EPS.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) last announced its quarterly earnings results on Wednesday, November 8th. The company reported $0.09 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.13. The company had revenue of $39.68 million during the quarter, compared to the consensus estimate of $38.22 million. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share had a net margin of 44.47% and a return on equity of 33.92%. The company’s revenue for the quarter was up 23.7% compared to the same quarter last year. During the same period in the prior year, the business earned ($0.08) earnings per share.

AVDL has been the subject of several other reports. Zacks Investment Research downgraded shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a “hold” rating to a “sell” rating in a report on Monday, October 16th. BidaskClub upgraded shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share from a “strong sell” rating to a “sell” rating in a report on Saturday, December 9th. Finally, Roth Capital set a $14.00 price target on shares of Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share and gave the stock a “buy” rating in a report on Wednesday, January 3rd. One analyst has rated the stock with a sell rating, one has assigned a hold rating and two have given a buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $21.50.

Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL) opened at $10.51 on Friday. The stock has a market cap of $421.28, a price-to-earnings ratio of 19.46 and a beta of 1.34. The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.47 and a current ratio of 1.53. Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share has a 1-year low of $7.52 and a 1-year high of $12.30.

In related news, Director Craig R. Stapleton sold 254,265 shares of the stock in a transaction on Monday, November 27th. The stock was sold at an average price of $9.35, for a total value of $2,377,377.75. Following the completion of the sale, the director now directly owns 253,413 shares in the company, valued at $2,369,411.55. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Craig R. Stapleton acquired 140,000 shares of the firm’s stock in a transaction that occurred on Friday, December 15th. The stock was bought at an average price of $8.67 per share, with a total value of $1,213,800.00. The disclosure for this purchase can be found here. 5.07% of the stock is currently owned by corporate insiders.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. State Street Corp increased its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 1.7% in the second quarter. State Street Corp now owns 31,782 shares of the company’s stock valued at $351,000 after purchasing an additional 523 shares during the period. Stifel Financial Corp increased its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 4.3% in the second quarter. Stifel Financial Corp now owns 60,500 shares of the company’s stock valued at $667,000 after purchasing an additional 2,500 shares during the period. Trexquant Investment LP increased its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 18.7% in the third quarter. Trexquant Investment LP now owns 36,218 shares of the company’s stock valued at $380,000 after purchasing an additional 5,718 shares during the period. State of Tennessee Treasury Department increased its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 32.7% in the third quarter. State of Tennessee Treasury Department now owns 23,291 shares of the company’s stock valued at $245,000 after purchasing an additional 5,736 shares during the period. Finally, PNC Financial Services Group Inc. increased its holdings in Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share by 2,484.0% in the second quarter. PNC Financial Services Group Inc. now owns 10,956 shares of the company’s stock valued at $121,000 after purchasing an additional 10,532 shares during the period. Institutional investors and hedge funds own 67.75% of the company’s stock.

TRADEMARK VIOLATION NOTICE: “FY2019 EPS Estimates for Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share Boosted by SunTrust Banks (AVDL)” was first published by The Lincolnian Online and is owned by of The Lincolnian Online. If you are accessing this piece on another domain, it was illegally stolen and reposted in violation of United States & international trademark & copyright laws. The original version of this piece can be accessed at https://www.thelincolnianonline.com/2018/01/14/fy2019-eps-estimates-for-avadel-pharmaceuticals-plc-american-depositary-shares-each-representing-one-ordinary-share-boosted-by-suntrust-banks-avdl.html.

About Avadel Pharmaceuticals plc – American Depositary Shares each representing one Ordinary Share

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is a specialty pharmaceutical company that seeks to commercialize differentiated pharmaceutical products that are safe, effective and easy to take through formulation development, by utilizing its proprietary drug delivery technology and in-licensing / acquiring new products; ultimately, helping patients adhere to their prescribed medical treatment and see better results.

Earnings History and Estimates for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share (NASDAQ:AVDL)

Receive News & Ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply